U.S. pharmaceutical stocks declined, with BioNTech (BNTX.US) dropping 11%, marking its largest intraday loss since March 10, after the company announced the termination of its Phase II colorectal cancer clinical trial. Moderna (MRNA.US) fell 5%, and Merck (MRK.US) dropped 1.3%.

Marvell's FY29 In Focus After Lukewarm 2Q Showing -- Market Talk

New York silver futures fell by 2% intraday, currently quoted at $68.79 per ounce. Note: This price fluctuation is influenced by multiple market factors, and the future trend of precious metal prices requires further observation based on global macroeconomic policies, the direction of the US Dollar Index, market risk appetite, and other dimensions.

The spot gold price has fallen below the $4,520 per ounce mark, with a daily decline of 1.78%. As a precious metal with both safe-haven and commodity attributes, gold's short-term price fluctuations are usually influenced by multiple factors, including the performance of the US dollar, expectations for Federal Reserve monetary policy, global geopolitical developments, and market risk appetite. This intraday pullback has also garnered significant attention from investors regarding the future tre

Bessent: Japan does not owe any debt to the U.S. Treasury, and the same logic applies to Argentina.